DEONNA CAMPBELL: Open Payments
NPI 1821664350 · PRESTONSBURG, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$568 in 28 payments from 16 companies in 2025. Trend: 2023 $659 · 2024 $701 · 2025 $568
Food & beverage: $568
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $106 |
| ABBVIE INC. | 4 | $86 |
| Vanda Pharmaceuticals Inc. | 2 | $56 |
| Axsome Therapeutics, Inc. | 3 | $50 |
| Indivior Inc. | 2 | $35 |
| Lilly USA, LLC | 2 | $34 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| Alkermes, Inc. | 1 | $23 |
| Corcept Therapeutics | 1 | $23 |
Products named: CAPLYTA, HETLIOZ, Auvelity, VRAYLAR, SUBLOCADE, MOUNJARO, QULIPTA, TRELEGY ELLIPTA.
Industry payments across KY — which companies pay providers there.
